Reducing Both Pgp Overexpression and Drug Efflux with Anti-Cancer Gold-Paclitaxel Nanoconjugates

Open Access

Peer-reviewed

Research Article

Fei Li,

Affiliation School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China
⨯
Xiaofei Zhou,

Affiliation School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China
⨯
Hongyu Zhou,

Affiliation School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China
⨯
Jianbo Jia,

Affiliation School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China
⨯
Liwen Li,

Affiliation School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China
⨯
Shumei Zhai ,

* E-mail: bingyan@yahoo.com (BY); smzhai@sdu.edu.cn (SZ)

Affiliation School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China
⨯
Bing Yan

* E-mail: bingyan@yahoo.com (BY); smzhai@sdu.edu.cn (SZ)

Affiliation School of Chemistry and Chemical Engineering, Shandong University, Jinan, 250100, China
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Nanoparticles
Is the Subject Area "Nanoparticles" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Cytotoxicity
Is the Subject Area "Cytotoxicity" applicable to this article?

Thanks for your feedback.
Drug delivery
Is the Subject Area "Drug delivery" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.